70 Works
Sacrificial Wind Screenplay
Lorna ShaughnessyAdditional file 1 of Development of a co-designed behaviour change intervention aimed at healthcare professionals recruiting to clinical trials in maternity care
Vivienne Hanrahan, Louisa Lawrie, Eilidh Duncan, Linda Biesty & Katie Gillies
Additional file 1: Supp. File 1: GUIDED checklist and TIDieR checklist.
Additional file 2 of Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis
Nicola Farrar, Daisy Elliott, Catherine Houghton, Marcus Jepson, Nicola Mills, Sangeetha Paramasivan, Lucy Plumb, Julia Wade, Bridget Young, Jenny L. Donovan & Leila Rooshenas
Additional file 2. Screening Form. Form used to aid reviewers when screening papers for inclusion.
Additional file 6 of Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis
Nicola Farrar, Daisy Elliott, Catherine Houghton, Marcus Jepson, Nicola Mills, Sangeetha Paramasivan, Lucy Plumb, Julia Wade, Bridget Young, Jenny L. Donovan & Leila Rooshenas
Additional file 6. Full EP. GRADE CERQual full evidence profile.
Additional file 8 of Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis
Nicola Farrar, Daisy Elliott, Catherine Houghton, Marcus Jepson, Nicola Mills, Sangeetha Paramasivan, Lucy Plumb, Julia Wade, Bridget Young, Jenny L. Donovan & Leila Rooshenas
Additional file 8. Recruiter Roles. Outline of the roles of the recruiters included in the synthesis.
Additional file 7 of The effectiveness and acceptability of evidence synthesis summary formats for clinical guideline development groups: a mixed-methods systematic review
Melissa K. Sharp, Dayang Anis Binti Awang Baki, Joan Quigley, Barrie Tyner, Declan Devane, Kamal R. Mahtani, Susan M. Smith, Michelle O’Neill, Máirín Ryan & Barbara Clyne
Additional file 7. Qualitative synthesis recommendations (with at least 3 supporting studies or mixed methods support).
Additional file 4 of Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
Alok Joshi, Stephen Todd, David P. Finn, Paula L. McClean & KongFatt Wong-Lin
Additional file 4. Features used for association study.
Additional file 4 of Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
Alok Joshi, Stephen Todd, David P. Finn, Paula L. McClean & KongFatt Wong-Lin
Additional file 4. Features used for association study.
Supplemental Material - PROMoting the use of studies within a trial (PROMETHEUS): Results and experiences from a large programme to evaluate the routine embedding of recruitment and retention strategies within randomised controlled trials routinely
Laura Doherty, Adwoa Parker, Catherine Arundel, Laura Clark, Elizabeth Coleman, Catherine Hewitt, David Beard, Peter Bower, Paul Brocklehurst, Cindy Cooper, Lucy Culliford, Declan Devane, Richard Emsley, Sandra Eldridge, Sandra Galvin, Katie Gillies, Alan Montgomery, Chris Sutton, Shaun Treweek & David Torgerson
Supplemental Material for PROMoting the use of studies within a trial (PROMETHEUS): Results and experiences from a large programme to evaluate the routine embedding of recruitment and retention strategies within randomised controlled trials routinely by Laura Doherty, Adwoa Parker, Catherine Arundel, Laura Clark, Elizabeth Coleman, Catherine Hewitt, David Beard, Peter Bower, Paul Brocklehurst, Cindy Cooper, Lucy Culliford, Declan Devane, Richard Emsley, Sandra Eldridge, Sandra Galvin, Katie Gillies, Alan Montgomery, Chris Sutton, Shaun Treweek, David Torgerson...
Determinants of implementing pet robots in nursing homes for dementia care
Wei Qi Koh, ELAINE TOOMEY, Aisling Flynn & Dympna Casey
Background: Pet robots have been employed as viable substitutes to pet therapy in nursing homes. Despite their potential to enhance the psychosocial health of residents with dementia, there is a lack of studies that have investigated determinants of implementing pet robots in real-world practice. This study aims to explore the determinants of implementing pet robots for dementia care in nursing homes, from the perspectives of healthcare professionals and organisational leaders. Methods: A descriptive qualitative study,...
Additional file 2 of What is the purpose of clinical trial monitoring?
Sharon B. Love, Victoria Yorke-Edwards, Elizabeth Ward, Rebecca Haydock, Katie Keen, Katie Biggs, Gosala Gopalakrishnan, Lucy Marsh, Lydia O’Sullivan, Lisa Fox, Estelle Payerne, Kerenza Hood & Garry Meakin
Additional file 2. Questions used in UKCRC Task and Finish Monitoring Group annual meeting 9 June 2021.
Additional file 3 of The multimorbidity collaborative medication review and decision making (MyComrade) study: a pilot cluster randomised trial in two healthcare systems
Collette Kirwan, Lisa Hynes, Nigel Hart, Sarah Mulligan, Claire Leathem, Laura McQuillan, Marina Maxwell, Emma Carr, Kevin Roche, Scott Walkin, Caroline McCarthy, Colin Bradley, Molly Byrne, Susan M. Smith, Carmel Hughes, Maura Corry, Patricia M. Kearney, Geraldine McCarthy, Margaret Cupples, Paddy Gillespie, Anna Hobbins, John Newell, Liam Glynn, Davood Roshan, Carol Sinnott … & Andrew W. Murphy
Additional file 3. Communication [11, 12, 30, 48].
Strategies for implementing pet robots in care homes and nursing homes for residents with dementia: protocol for a modified Delphi study
Wei Qi Koh, Dympna Casey, Viktoria Hoel & ELAINE TOOMEY
Background: Pet robots are a type of technology-based innovation that have shown positive psychosocial benefts for people with dementia in residential facilities, such as improving mood and social interaction and reducing agitation. Nevertheless, little is known about how pet robots can be implemented in care homes and nursing homes for dementia care in real-world practice. The objectives of this study are to (1) identify contextualised implementation strategies for implementing pet robots into care homes and...
Additional file 2 of The effectiveness and acceptability of evidence synthesis summary formats for clinical guideline development groups: a mixed-methods systematic review
Melissa K. Sharp, Dayang Anis Binti Awang Baki, Joan Quigley, Barrie Tyner, Declan Devane, Kamal R. Mahtani, Susan M. Smith, Michelle O’Neill, Máirín Ryan & Barbara Clyne
Additional file 2. Search strategy results.
How do the mutations in PfK13 protein promote anti-malarial drug resistance?
Shikha Sharma & Md. Ehesan Ali
Plasmodium falciparum develops resistance to artemisinin upon exposure to the anti-malarial drug. Various mutations in the Plasmodium falciparum Kelch13 (PfK13) protein such as Y493H, R539T, I543T and C580Y have been associated with anti-malarial drug resistance. These mutations impede the regular ubiquitination process that eventually invokes drug resistance. However, the relationship between the mutation and the mechanism of drug resistance has not yet been fully elucidated. The comparative protein dynamics are studied by performing the classical...
How do the mutations in PfK13 protein promote anti-malarial drug resistance?
Shikha Sharma & Md. Ehesan Ali
Plasmodium falciparum develops resistance to artemisinin upon exposure to the anti-malarial drug. Various mutations in the Plasmodium falciparum Kelch13 (PfK13) protein such as Y493H, R539T, I543T and C580Y have been associated with anti-malarial drug resistance. These mutations impede the regular ubiquitination process that eventually invokes drug resistance. However, the relationship between the mutation and the mechanism of drug resistance has not yet been fully elucidated. The comparative protein dynamics are studied by performing the classical...
Additional file 2 of The multimorbidity collaborative medication review and decision making (MyComrade) study: a pilot cluster randomised trial in two healthcare systems
Collette Kirwan, Lisa Hynes, Nigel Hart, Sarah Mulligan, Claire Leathem, Laura McQuillan, Marina Maxwell, Emma Carr, Kevin Roche, Scott Walkin, Caroline McCarthy, Colin Bradley, Molly Byrne, Susan M. Smith, Carmel Hughes, Maura Corry, Patricia M. Kearney, Geraldine McCarthy, Margaret Cupples, Paddy Gillespie, Anna Hobbins, John Newell, Liam Glynn, Davood Roshan, Carol Sinnott … & Andrew W. Murphy
Additional file 2. Incentives [6, 8, 17].
Additional file 1 of What is the purpose of clinical trial monitoring?
Sharon B. Love, Victoria Yorke-Edwards, Elizabeth Ward, Rebecca Haydock, Katie Keen, Katie Biggs, Gosala Gopalakrishnan, Lucy Marsh, Lydia O’Sullivan, Lisa Fox, Estelle Payerne, Kerenza Hood & Garry Meakin
Additional file 1. Sources used for the paper.
Additional file 3 of Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis
Nicola Farrar, Daisy Elliott, Catherine Houghton, Marcus Jepson, Nicola Mills, Sangeetha Paramasivan, Lucy Plumb, Julia Wade, Bridget Young, Jenny L. Donovan & Leila Rooshenas
Additional file 3. Eligible Not Included Studies. References of studies that were eligible for the synthesis but not included.
Additional file 3 of Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis
Nicola Farrar, Daisy Elliott, Catherine Houghton, Marcus Jepson, Nicola Mills, Sangeetha Paramasivan, Lucy Plumb, Julia Wade, Bridget Young, Jenny L. Donovan & Leila Rooshenas
Additional file 3. Eligible Not Included Studies. References of studies that were eligible for the synthesis but not included.
Additional file 4 of Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis
Nicola Farrar, Daisy Elliott, Catherine Houghton, Marcus Jepson, Nicola Mills, Sangeetha Paramasivan, Lucy Plumb, Julia Wade, Bridget Young, Jenny L. Donovan & Leila Rooshenas
Additional file 4. CASP. Critical Appraisal Skills Programme for appraising a qualitative study.